COVID-19 Infection in Patients With Chronic Pulmonary Diseases.

• Sponsor: Sohag University (Other)
• Overall Status: Not yet recruiting
• CT.gov ID: NCT05087199
• Collaborator: (none)
• Enrollment: 100
• Anticipated Duration (Months): 8.9

Study Details

Study Description

Brief Summary

This study aims to assess the clinical presentation, radiological patterns and outcome of COVID-19 infection in patients with chronic pulmonary disease.

Inter-relationship between the severity of COVID-19 infection and chronic pulmonary diseases.

Condition or Disease	Intervention/Treatment	Phase
COVID-19; Chronic Pulmonary Disease	Diagnostic Test: Rt-PCR.

Detailed Description

The COVID-19 pandemic has led to many difficulties with the diagnosis and routine management of chronic pulmonary diseases such as COPD, Bronchial asthma, ILD and Bronchiectasis as well as raising concerns about the management and outcomes for patients with these diseases who develop COVID-19.

Although there is conflicting evidence on whether patients with chronic respiratory diseases are more susceptible to COVID-19, these patients exhibit a more severe presentation and higher mortality compared with those without chronic respiratory diseases.

Study Design

• Study Type: Observational
• Anticipated Enrollment: 100 participants
• Observational Model: Case-Only
• Time Perspective: Cross-Sectional
• Official Title: COVID-19 Infection in Patients With Chronic Pulmonary Diseases.
• Anticipated Study Start Date: Nov 1, 2021
• Anticipated Primary Completion Date: Jun 30, 2022
• Anticipated Study Completion Date: Jul 30, 2022

Outcome Measures

Primary Outcome Measures

1. Effect of COVID-19 on patients with chronic pulmonary diseases [2 weeks after patient confirmation of infection by COVID-19]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 16 Years to 100 Years
• Sexes Eligible for Study: All

Inclusion Criteria:

• Subjects with confirmed diagnosis of COVID-19 infection by:

RT-PCR And Chest Computed tomography and laboratoty investigations. Patients with chronic chest disease including (COPD, bronchial asthma, ILD, bronchiectasis).

Exclusion Criteria:

• Those who are diagnosed with viral pneumonia caused by viruses other than COVID-19.

Those who are not confirmed to be COVID-19 with PCR or by radiological and laboratory investigations.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Sohag University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Mostafa Mahmoud Elsayed, Principal Investigator, Sohag University
• ClinicalTrials.gov Identifier: NCT05087199
• Other Study ID Numbers: OHRP#:IRB00013006
• First Posted: Oct 21, 2021
• Last Update Posted: Nov 2, 2021
• Last Verified: Oct 1, 2021

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Mostafa Mahmoud Elsayed, Principal Investigator, Sohag University: COVID-19; Chronic pulmonary disease
• Additional relevant MeSH terms: COVID-19; Lung Diseases; Fibrin fragment D

Study Results

No Results Posted as of Nov 2, 2021